Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient

Transpl Infect Dis. 2012 Dec;14(6):E161-5. doi: 10.1111/tid.12017. Epub 2012 Nov 2.

Abstract

We present a case of severe Clostridium difficile infection (CDI) in a non-neutropenic allogeneic hematopoietic stem cell transplant recipient who was treated successfully with fecal microbiota therapy after standard pharmacologic therapy had failed. Following naso-jejunal instillation of donor stool, the patient's symptoms resolved within 48 h. Bowel resection was averted. This is the first case in the literature, to our knowledge, to describe fecal microbiota therapy in a profoundly immunocompromised host with severe CDI. We propose that fecal microbiota therapy be considered as a therapeutic option in immunosuppressed patients with refractory severe CDI.

Publication types

  • Case Reports

MeSH terms

  • Clostridioides difficile
  • Enterocolitis, Pseudomembranous / etiology
  • Enterocolitis, Pseudomembranous / therapy*
  • Feces / microbiology*
  • Female
  • Humans
  • Immunocompromised Host
  • Intestines / microbiology
  • Stem Cell Transplantation / adverse effects*
  • Treatment Outcome
  • Young Adult